Table 3.
Pre- to post-treatment | Pre-treatment to follow-up | |
---|---|---|
HADS total | ||
Anxiety Comorbid Total sample |
1.68 1.82 1.73 |
1.13 1.86 1.48 |
PMC | ||
Anxiety Comorbid Total sample |
2.33 2.07 2.13 |
1.92 1.94 1.85 |
NMC | ||
Anxiety Comorbid Total sample |
2.45 1.95 1.82 |
1.51 1.87 1.67 |